Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA clears new formulation of Imitrex

Sep. 1, 1997

FKBP12 inhibitors in the pipeline at Guilford

Aug. 29, 1997

New Parkinson's disease treatment option now available in Canada

Aug. 28, 1997

Morphine derivatives discovered by Nycomed

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Neurochemical actions of ARL-12495AA, the active metabolite of remacemide

Aug. 28, 1997

Immune Response's TCR vaccine evaluated in MS patients

Aug. 28, 1997

Calcium channel antagonist AJ-3941 for treatment of stroke

Aug. 27, 1997

S-15535 tested in preclinical models of anxiety and depression

Aug. 27, 1997

New treatment option for cancer pain

Aug. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...